Results for kardjo translation from Maltese to English

kardjo/ pulmonari oħrajn
0.8 0.2 0.2 0.1 0.1

analettiċi kardjo - ċirkulatorji - s
cardio-circulatory analeptics -

analettiċi kardjo - ċirkolatorji - sympathimometics
cardio-circulatory analeptics - sympathomimetics

mhux komuni: problemi kardjo-respiratorji, bradikardija, palpitazzjonijiet
uncommon: cardio-respiratory distress, bradycardia, palpitations rare: angina pectoris, heart rate irregular

dan jista’ jkun assoċjat ma’ komplikazzjonijiet kardjo-vaskulari b’periklu għall-ħajja.
this may be associated with life-threatening cardiovascular complications.

attenzjoni speċjali hi rrakkomandata għal pazjenti fi stat ta’ prestazzjoni mnaqqsa u b’mard kardjo- pulmonari li kien jeżisti minn qabel.
special attention is recommended for patients with reduced performance status and pre-existing cardio- pulmonary disease.

mhux komuni: problemi kardjo- respiratorji, angina pectoris, qalb tħabbat bil- mod, qalb tħabbat b’ mod irregolari
uncommon: cardio-respiratory distress, angina pectoris, bradycardia, heart rate irregular

id- difetti l- aktar rappurtati ta ’ spiss huma cleft lip, malformazzjonijiet kardjo- vaskulari u difetti fit- tubu nevralġiku.
the most frequently reported defects are cleft lip, cardiovascular malformations and neural tube defects.

avvenimenti akuti relatati ma’ l-infuzjoni li ġew irrapportati f’> 0.1% u ≤ 1% ta’ pazjenti ttrattati b’abatacept inkludew sintomi kardjo-pulmonari bħal pressjoni baxxa, żieda fil-pressjoni, tnaqqis fil- pressjoni u dispneja; sintomi oħra nkludew dardir, fwawar, urtikarja, sogħla, sensittività eċċessiva, ħakk, raxx u tħarħir.
acute infusion-related events that were reported in > 0.1% and ≤ 1% of patients treated with abatacept included cardiopulmonary symptoms such as hypotension, increased blood pressure, decreased blood pressure, and dyspnea; other symptoms included nausea, flushing, urticaria, cough, hypersensitivity, pruritus, rash, and wheezing.